TY  - JOUR
AU  - Llaneras, Jordi
AU  - Riveiro-Barciela, Mar
AU  - Lens, Sabela
AU  - Diago, Moisés
AU  - Cachero, Alba
AU  - García-Samaniego, Javier
AU  - Conde, Isabel
AU  - Arencibia, Ana
AU  - Arenas, Juan
AU  - Gea, Francisco
AU  - Torras, Xavier
AU  - Luis Calleja, José
AU  - Antonio Carrión, José
AU  - Fernández, Inmaculada
AU  - María Morillas, Rosa
AU  - Rosales, José Miguel
AU  - Carmona, Isabel
AU  - Fernández-Rodríguez, Conrado
AU  - Hernández-Guerra, Manuel
AU  - Llerena, Susana
AU  - Bernal, Vanesa
AU  - Turnes, Juan
AU  - González-Santiago, Jesús M
AU  - Montoliu, Silvia
AU  - Figueruela, Blanca
AU  - Badia, Ester
AU  - Delgado, Manuel
AU  - Fernández-Bermejo, Miguel
AU  - Iñarrairaegui, Mercedes
AU  - Pascasio, Juan Manuel
AU  - Esteban, Rafael
AU  - Mariño, Zoe
AU  - Buti, Maria
PY  - 2019
DO  - 10.1016/j.jhep.2019.06.002
UR  - http://hdl.handle.net/10668/14121
T2  - Journal of hepatology
AB  - Around 5% of patients with chronic hepatitis C virus (HCV) infection treated with direct-acting antiviral (DAA) agents do not achieve sustained virological response (SVR). The currently approved retreatment regimen for prior DAA failure is a...
LA  - en
KW  - HCV genotype 3
KW  - Hepatitis C
KW  - Sofosbuvir
KW  - Treatment failures
KW  - Velpatasvir
KW  - Voxilaprevir
KW  - Adult
KW  - Aminoisobutyric Acids
KW  - Antiviral Agents
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug Combinations
KW  - Drug Monitoring
KW  - Drug Resistance, Viral
KW  - Female
KW  - Hepacivirus
KW  - Hepatitis C, Chronic
KW  - Heterocyclic Compounds, 4 or More Rings
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Leucine
KW  - Liver Cirrhosis
KW  - Macrocyclic Compounds
KW  - Male
KW  - Middle Aged
KW  - Proline
KW  - Quinoxalines
KW  - Sofosbuvir
KW  - Spain
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Treatment Outcome
TI  - Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs.
TY  - research article
VL  - 71
ER  -